Onyx Stock Hits New 52-Week High (ONXX)
NEW YORK (
) --
(Nasdaq:
) hit a new 52-week high Tuesday as it is currently trading at $133.40, above its previous 52-week high of $132.98 with 1.1 million shares traded as of 10:01 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Onyx has a market cap of $6.32 billion and is part of the health care sector and drugs industry. Shares are up 14.9% year to date as of the close of trading on Monday.
Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Onyx
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. You can view the full
.
See all
52-week high stocks
or get investment ideas from our
.
.
null